The aprevo implants enable personalized correction for spinal deformities, the release said. Financing was led by U.S. Venture Partners.
“This round of financing comes at the perfect time to meet surgeon and patient demand for the newly launched breakthrough aprevo devices,” Carlsbad CEO Mike Cordonnier said in the release. “U.S. Venture Partners is the right fit for our digital and surgical company, being the leading Silicon Valley VC focused on early stage IT and healthcare. Their track record of building and scaling transformative companies is second to none.”
New leadership was also named in the release. Jonathan Root, MD, Phil Young and Kevin Sidow were named as company directors. Frank Fitzgerald will be vice president of sales.
Read more details here.
More articles on devices:
DOJ continues kickback crackdown: 4 big cases in spine this year
Medtronic gets FDA clearance to advance Mazor platform
Mayo Clinic neurosurgeon featured in Netflix docuseries
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.